Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes by James Goodman, Martin Schain, Giovanni Di Stefano, Victoria Lupson, Tracy Horn, Marion Hill, Roie Manavaki, Timothy D. Fryer, Elaine Bumanlag-Amis, Navazh Jalaludeen, Lutz Jermutus, Edvin Johansson, Kerstin Heurling, Henrik Haraldsson, Mark Evans, Joseph Cheriyan, Lars Johansson, Philip Ambery, Ian B. Wilkinson

Get full text

Efficacy and safety of dapagliflozin in patients hospitalized with COVID-19 with and without type 2 diabetes: a prespecified analysis of the DARE-19 randomized trial by Mohammad Abdel Jawad, Remo H. M. Furtado, Russell Esterline, Jan Oscarsson, Samvel B. Gasparyan, Gary G. Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Anna Maria Langkilde, Philip Ambery, Shachi Patel, Kensey Gosch, Sheryl L. Windsor, Ronaldo V. P. Soares, Diogo D. F. Moia, Matthew Aboudara, Ali Javaheri, J. F. Kerr Saraiva, Lilia Nigro Maia, Otavio Berwanger, Andrew J. Sauer, Mikhail N. Kosiborod

Get full text